Login    Join free Add to favorites    中文
Home >Products> Reagents >Molecular Biology> SARS-CoV-2(2019-nCOV) Coronavirus and Influenza A/B Virus Multiplex RT-qPCR Detection Kits
SARS-CoV-2(2019-nCOV) Coronavirus and Influenza A/B Virus Multiplex RT-qPCR Detection Kits
Origin of place China
Model
Supplier Shanghai ShineGene Molecular Biotech,Inc.
Price $1200.00/50T
Hits 510
Updated 3/21/2020
  • Product Detail
  • Company Profile

SARS-CoV-2(2019-nCOV) Coronavirus and Influenza A/B Virus Multiplex RT-qPCR Detection Kits

Catalog #

Pack size

Price($)

COV00102

50tests

1200.00

COV00103

100tests

2160.00

This kit is used for in vitro diagnostics for 2019-Novel Coronavirus (2019-nCoV) infection including suspected case, suspected aggregative diseases and other scenarios. By testing the suspected person’s respiratory specimen, serum or blood, the kit can tell if the specimens contain any virus RNA, so it can be used for clinical screening of suspected cases.
       Select the 2019-nCoV N gene and E gene as the target amplifying area, design specific primer and fluorescent probes, use FAM label, detect if the specimen contains any 2019 nCoV RNA. Select the 2019-nCoV ORF1ab gene, design specific primer and florescent probes, use ROX label, detect if the specimen contains any 2019-nCoV RNA. Select influenza A/B specific sequence, design specific primer and fluorescent probes, use Cy5 label, detect if the specimen contains any influenza A/B virus RNA. Select other species’ sequence (none-human and none-targeted sequence) as internal primer/probe, label with VIC, monitor the whole process.
        The kit also contains UNG enzyme anti-contamination system. Its theory is it selectively hydrolyzes Uracil glycoside bond in the single or double chain of DNA that contains dU. This leads to a DNA chain with nucleotide deletion which will further hydrolyzed in alkaline media under high temperature and thus avoid contamination by PCR amplification.

                                                                        4 Fluorescent Signals and Target

 

Fluorescent signal

Target

1

FAM

2019-nCoV N gene and E gene

2

ROX

2019-nCoV ORF1ab gene

3

Cy5

Influenza A/B specific sequence

4

VIC

MS2 internal standard (RNA Phage pseudo virus)

 

 Key Features 
1.High sensitivity 500 copy/ml 
2.Very specific, can detect 2019-nCoV E gene, N gene and ORF1ab different zone sequence at the same time in one tube.
3.Can simultaneously identify and distinguish influenza viruses to avoid misdiagnosis. 
4.One-step RT-PCR, strong amplification signal, high stability. 
Storage condition -20°C. 
Equipment RequirementsFluorescent PCR amplifier; Fluorescent PCR amplifier with 4 colors or multi-color fluorescent PCR amplifier  such as  ABI Prism®7500, Bio-rad CFX96 etc.
Set up reaction mixture:

Component

Volume(μL)

RT-mix

Nx 9

Enzyme mix

Nx 1.5

2019-nCoV primer probe

Nx 1

Influenza A/B primer probe

Nx 1

Total volume

Nx 12.5

 

Set up cycle program:
 

Step

Temp

Time

Cycles

1

UNG Incubation

25°C

2min

1

2

RT incubation

50℃

10min

1

3

Enzyme activation

95℃

2min

1

4

Denature

95℃

5sec

45

Annealing, extension, detction*

60℃

35sec

*Fluorescent test in extension:
Channel for 2019-nCoV E gene and N gene is FAM; Channel for 2019-nCoV ORF1ab gene is ROX;
Channel for influenza A/B is Cy5;
Channel for internal standard is VIC;

 

Data Analysis:

Ct Value*

Result

Recommendations

Ct(FAM)≤36.5 and Ct(ROX)≤38

2019-nCoV positive(+)

Active treatment

Ct(FAM、ROX)≥39 or no value,and Ct(VIC)<40

2019-nCoV negative(-)

More Rest

Ct(FAM、ROX)≥39 or no value,and Ct(VIC)<40,but Ct(Cy5) ≤36.5

2019-nCoV negative(-)

Influenza A/B positive(+)

Active treatment

Ct(FAM)≤36.5 and Ct(ROX)≤38,and Ct(Cy5) ≤36.5

2019-nCoV negative(+)

Influenza A/B positive(+)

Active treatment

 only Ct(FAM)≤36.5 or Ct(ROX)≤38

 Inconclusive Result

Repeat extraction and double confirm. After getting Ct(FAM)≤36.5 or Ct(ROX)≤38, the result is positive

  

36.5<Ct(FAM)<39 or 38<Ct(ROX)<39

  

Inconclusive Result

Increase specimen concentration and double confirm. If Ct(FAM)<39 and Ct(ROX)<39, it means 2019-nCoV result is positive; other results need be analyzed by other methods.

 Ct(FAM、ROX、CY5)≥39 or no value,and Ct(VIC)≥40 or no value

 Invalid Result

Indicates that there might be issues with experiment itself, reagent, need check before repeat the experiment

 SARS-CoV-2(2019-nCOV) Coronavirus and Influenza A/B Virus Multiplex RT-qPCR Detection Kits
  Handbook of COVID-19 Prevention and Treatment
------------------------------------------------------------------------------
Floor 2,Gate 6,289#,Minqiang Road,Songjiang District,Shanghai 201612,China
Tel:0086-21-54460832    Fax:0086-21-54460831-13    E-mail:master@shinegene.org.cn

bio-equip.cn
Request Infomation

* Name:
Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request infomation:
yes no
Request Quotation:
yes no
* Message:
Validated Code:
refresh
I agree to share my inquiry to the other matching suppliers.



Copyright(C) 2006-2025 Bio-Equip    E-mail:web@bio-equip.cn   沪ICP备06040519号